Kara Scheibner
Impact in
- Immunology top 10%
- Immune Response and Inflammation
- Cell Biology top 5%
- Proteoglycans and glycosaminoglycans research
Papers in ⓘ
-
- MicroRNA in disease regulation 3
- Co-authors
- Jonathan D. Powell (3 shared papers)Maureen R. Horton (3 shared papers)Matthew J. Fenton (1 shared paper)Michael A. Lutz (1 shared paper)Curt I. Civin (4 shared papers)Yee Chan‐Li (2 shared papers)Katharine E. Black (2 shared papers)Samuel L. Collins (2 shared papers)
- Journals
- Blood (2 papers)Molecular Cancer Research (1 paper)Bioanalysis (1 paper)Journal of Interferon & Cytokine Research (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesPolandCanada
In The Last Decade
Kara Scheibner
11 papers receiving 923 citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Immunology 286
- Cell Biology 220
- Immunology and Allergy 52
- Cancer Research 125
- Hematology 83
Countries citing papers authored by Kara Scheibner
This map shows the geographic impact of Kara Scheibner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Scheibner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Scheibner more than expected).
Fields of papers citing papers by Kara Scheibner
This network shows the impact of papers produced by Kara Scheibner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Scheibner. The network helps show where Kara Scheibner may publish in the future.
Co-authors
The 25 scholars most cited alongside Kara Scheibner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2 Hit paper breakdown → | 2006 | 547 |
| 2 | 2013 | 110 | |
| 3 | 2015 | 54 | |
| 4 | 2012 | 53 | |
| 5 | 2008 | 53 | |
| 6 | 2008 | 44 | |
| 7 | 2012 | 29 | |
| 8 | 2001 | 23 | |
| 9 | 2003 | 19 | |
| 10 | 2010 | 1 | |
| 11 | 2016 | 1 |
About Kara Scheibner
Kara Scheibner is a scholar working on Physiology, Cancer Research, Immunology, Cell Biology and Biophysics, having authored 11 papers that have together received 934 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Immune Response and Inflammation (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Plant Molecular Biology Research (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Signaling Pathways in Disease (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Immunology (286 citations), Cell Biology (220 citations), Immunology and Allergy (52 citations), Cancer Research (125 citations) and Hematology (83 citations). Kara Scheibner has collaborated with scholars based in United States, Poland and Canada. Frequent co-authors include Jonathan D. Powell, Maureen R. Horton, Matthew J. Fenton, Michael A. Lutz, Curt I. Civin, Yee Chan‐Li, Katharine E. Black, Samuel L. Collins, Feyruz V. Rassool and Philip A. Cole. Their work appears in journals such as Blood, Molecular Cancer Research, Bioanalysis, Journal of Interferon & Cytokine Research and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.